Citations 2
Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention (P3-1.002)
Vilaseca-Jolonch, Andreu, Syc-Mazurek, Stephanie, Guo, Kai, Niederschweiberer, Moritz, Sagen, Jessica, Lopez-Chiriboga, Sebastian, Wingerchuk, Dean, Tillema, Jan-Mendelt, Pittock, Sean, Chen, John, Flanagan, Eoin , Thakolwiboon, Smathorn , Syc‐Mazurek, Stephanie B. , Cacciaguerra, Laura , Niederschweiberer, Moritz , López‐Chiriboga, A. Sebastian , Tillema, Jan‐Mendelt , Pittock, Sean J. , Flanagan, Eoin P.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Frequency of Optic Nerve Enhancement During Acute Optic Neuritis in MOG Antibody-associated Disease (S6.004)
Syc-Mazurek, Stephanie, Tisavipat, Nanthaya, Farnsworth, Paul, Niederschweiberer, Moritz, Bhatti, M. Tariq, Chodnicki, Kevin, Tajfirouz, Deena, Pittock, Sean, Flanagan, Eoin , Chen, John, Syc‐Mazurek, Stephanie B. , Tisavipat, Nanthaya , Rattanathamsakul, Natthapon , Farnsworth, Paul J. , Niederschweiberer, Moritz , Bhatti, M. Tariq , Chodnicki, Kevin D. , Tajfirouz, Deena , Pittock, Sean J. , Flanagan, Eoin P.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available